NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that it has rescheduled the announcement of its financial results and accompanying conference call for the third quarter ended September 30, 2008 to an earlier time. The Company will now announce its financial results before the opening of the U.S. financial markets on Thursday, November 6, 2008 and the accompanying conference call to discuss the results will be held at 8:00 am ET; 5:00 am PT.
